Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC), constituting around 20% of all BC, is characterized by the amplification of the ERBB2 gene on chromosome 17q12, resulting in an overexpression of the HER2 protein [1]. Here, ERBB2 is linked to breast cancer.